BMK-303
Solid Tumors (CAR‑T)
PreclinicalActive
Key Facts
About Biomakers
Argentinian biotech Biomakers develops engineered biologics for oncology and immunology using a proprietary protein‑engineering platform.
View full company profileSolid Tumors (CAR‑T)
Argentinian biotech Biomakers develops engineered biologics for oncology and immunology using a proprietary protein‑engineering platform.
View full company profile